198 related articles for article (PubMed ID: 34103536)
1. The stem cell revolution: on the role of CD164 as a human stem cell marker.
Watt SM; Bühring HJ; Simmons PJ; Zannettino AWC
NPJ Regen Med; 2021 Jun; 6(1):33. PubMed ID: 34103536
[TBL] [Abstract][Full Text] [Related]
2. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.
Watt SM; Bühring HJ; Rappold I; Chan JY; Lee-Prudhoe J; Jones T; Zannettino AC; Simmons PJ; Doyonnas R; Sheer D; Butler LH
Blood; 1998 Aug; 92(3):849-66. PubMed ID: 9680353
[TBL] [Abstract][Full Text] [Related]
3. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.
Zannettino AC; Bühring HJ; Niutta S; Watt SM; Benton MA; Simmons PJ
Blood; 1998 Oct; 92(8):2613-28. PubMed ID: 9763543
[TBL] [Abstract][Full Text] [Related]
4. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor.
Doyonnas R; Yi-Hsin Chan J; Butler LH; Rappold I; Lee-Prudhoe JE; Zannettino AC; Simmons PJ; Bühring HJ; Levesque JP; Watt SM
J Immunol; 2000 Jul; 165(2):840-51. PubMed ID: 10878358
[TBL] [Abstract][Full Text] [Related]
5. Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis.
Jorgensen-Tye B; Levesque JP; Royle L; Doyonnas R; Chan JY; Dwek RA; Rudd PM; Harvey DJ; Simmons PJ; Watt SM
Tissue Antigens; 2005 Mar; 65(3):220-39. PubMed ID: 15730515
[TBL] [Abstract][Full Text] [Related]
6. The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis.
Havens AM; Jung Y; Sun YX; Wang J; Shah RB; Bühring HJ; Pienta KJ; Taichman RS
BMC Cancer; 2006 Jul; 6():195. PubMed ID: 16859559
[TBL] [Abstract][Full Text] [Related]
7. CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis.
Huang AF; Chen MW; Huang SM; Kao CL; Lai HC; Chan JY
Mol Cancer; 2013 Oct; 12(1):115. PubMed ID: 24094005
[TBL] [Abstract][Full Text] [Related]
8. CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.
Chen WL; Huang AF; Huang SM; Ho CL; Chang YL; Chan JY
Oncotarget; 2017 Aug; 8(33):54115-54135. PubMed ID: 28903328
[TBL] [Abstract][Full Text] [Related]
9. Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells.
Forde S; Tye BJ; Newey SE; Roubelakis M; Smythe J; McGuckin CP; Pettengell R; Watt SM
Blood; 2007 Mar; 109(5):1825-33. PubMed ID: 17077324
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo.
Tang J; Zhang L; She X; Zhou G; Yu F; Xiang J; Li G
Cancer Invest; 2012 Jun; 30(5):380-9. PubMed ID: 22409183
[TBL] [Abstract][Full Text] [Related]
11. Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast.
Lee YN; Kang JS; Krauss RS
Mol Cell Biol; 2001 Nov; 21(22):7696-706. PubMed ID: 11604505
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164.
Bae GU; Gaio U; Yang YJ; Lee HJ; Kang JS; Krauss RS
J Biol Chem; 2008 Mar; 283(13):8301-9. PubMed ID: 18227060
[TBL] [Abstract][Full Text] [Related]
13. Cis-regulatory functions of overlapping HIF-1alpha/E-box/AP-1-like sequences of CD164.
Tang J; Luo Z; Zhou G; Song C; Yu F; Xiang J; Li G
BMC Mol Biol; 2011 Oct; 12():44. PubMed ID: 21999799
[TBL] [Abstract][Full Text] [Related]
14. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn.
Chan JY; Lee-Prudhoe JE; Jorgensen B; Ihrke G; Doyonnas R; Zannettino AC; Buckle VJ; Ward CJ; Simmons PJ; Watt SM
J Biol Chem; 2001 Jan; 276(3):2139-52. PubMed ID: 11027692
[TBL] [Abstract][Full Text] [Related]
15. CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.
Wysocka M; Kossenkov AV; Benoit BM; Troxel AB; Singer E; Schaffer A; Kim B; Dentchev T; Nagata S; Ise T; Showe LC; Rook AH
J Invest Dermatol; 2014 Jan; 134(1):229-236. PubMed ID: 23792457
[TBL] [Abstract][Full Text] [Related]
16. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.
Tu M; Cai L; Zheng W; Su Z; Chen Y; Qi S
Mol Med Rep; 2017 Apr; 15(4):1713-1721. PubMed ID: 28259931
[TBL] [Abstract][Full Text] [Related]
17. CD164--a novel sialomucin on CD34+ cells.
Watt SM; Chan JY
Leuk Lymphoma; 2000 Mar; 37(1-2):1-25. PubMed ID: 10721766
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Characterization of the Human Skeletal Stem Cell-like Properties of Primary Bone-Derived Mesenchymal Stem/Stromal Cells in Patients with Late and Early Hip Osteoarthritis.
Jasenc L; Stražar K; Mihelič A; Mihalič R; Trebše R; Haring G; Jeras M; Zupan J
Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743928
[TBL] [Abstract][Full Text] [Related]
19. CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.
Wang CC; Hueng DY; Huang AF; Chen WL; Huang SM; Yi-Hsin Chan J
Oncotarget; 2019 Mar; 10(21):2041-2054. PubMed ID: 31007847
[TBL] [Abstract][Full Text] [Related]
20. Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.
Watt SM; Butler LH; Tavian M; Bühring HJ; Rappold I; Simmons PJ; Zannettino AC; Buck D; Fuchs A; Doyonnas R; Chan JY; Levesque JP; Peault B; Roxanis I
Blood; 2000 May; 95(10):3113-24. PubMed ID: 10807777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
